COMPARISON OF THE EFFECTIVENESS OF GENE THERAPY AND STANDARD CONSERVATIVE THERAPY FOR PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA DUE TO ATHEROSCLEROSIS
https://doi.org/10.24884/0042-4625-2018-177-2-64-69
Abstract
OBJECTIVE. The objective is to compare the effectiveness of standard conservative therapy (SCT) and the complex therapy with preparation based on VEGF165 gene in patients with the stage II of chronic lower limb ischemia according to Fontaine classification during 5 years.
MATERIAL AND METHODS. In total, 92 patients were enrolled in the study. Patients were divided into 2 groups (n=46 for each group). In the first group, patients got only conservative therapy and in the second group, patients were received SCT in combination with injection of gene drug into the ischemic limb muscles.
RESULTS. The using of gene therapy in complex management in patients with the stage II of chronic lower limb ischemia led to significant increasing of the average pain-free walking distance (up to 500 %) (p=0.007). In addition, there were 65 % of the patients in the second group obtaining a significant and moderate improvement. By contrast, there was only 3 % of cases in the first group having similar results with standard therapy. Only gene therapy has statistically significance in the secondary parameters of treatment efficiency.
CONCLUSION. The efficiency of complex treatment with gene therapy in patients with the stage II of ch ronic lower limb ischemia for 5 years exceeds significantly the efficiency of standard conservative therapy.
About the Authors
Yu. V. ChervyakovRussian Federation
Yaroslavl
O. N. Vlasenko
Russian Federation
Yaroslavl
References
1. Hirsch A. T., Haskal Z. J., Hertzer N. R. et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease // J. Am. Coll. Cardiol. 2006. № 47 (6). Р. 1239–312.
2. Gavrilenko A. V., Voronov D. A., Bochkov N. L. Kompleksnoe lechenie pacientov s HINK s ispol’zovaniem gennyh induktorov angiogeneza: blizhajshie i otdalennye rezul’taty // Kletochnaja transplantologija i tkanevaja inzhenerija. 2011. Vol. 6, № 3. P. 84–88.
3. Tongers J., Roncalli J. G., Losordo D. W. Therapeutic Angiogenesis for Critical Limb Ischemia // Microvascular Therapies Coming of Age. 2008. № 118. Р. 9–16.
4. Nacional’nye rekomendacii po vedeniju pacientov s patologiej arterij nizhnih konechnostej // Angiologija i sosudistaja hirurgija. 2013. Vol. 19, № 2 (Pril.). P. 1–67.
5. ACC/AHA guidelines for the management of patients with peripheral arterial disease // J. Am. Coll. Cardiol. 2006. № 6. P. 1239–1312.
6. Shevchenko Ju. L., Matveeva S. A. Kletochnye tehnologii v serdechno-sosudistoj hirurgii. M.: Medicina, 2005.
7. Deev R. V., Bozo I. Ja., Mzhvanadze N. D. i dr. Jeffektivnost’ primenenija gena VEGF165 v kompleksnom lechenii pacientov s hronicheskoj ishemiej nizhnih konechnostej 2A-3 stadii // Angiologija i sosudistaja hirurgija. 2014. Vol. 20, № 2. P. 38–48.
8. Chervjakov Ju. V., Staroverov I. N., Vlasenko O. N. i dr. Otdalennye rezul’taty lech¬enija bol’nyh s hronicheskoj ishemiej nizhnih konechnostej metodami neprjamoj revaskuljarizacii i gennoj terapii // Angiologija i sosudistaja hirurgija. 2016. Vol. 22, № 1. P. 29–37.
9. Chervjakov Ju. V., Staroverov I. N., Vlasenko O. N. i dr. Pjatiletnie rezul’taty lechenija bol’nyh hronicheskoj ishemiej nizhnih konechnostej s ispol’zovaniem gennoj terapii // Angiologija i sosudistaja hirurgija. 2016. Vol. 22, № 4. P. 38–44.
10. Shval’b P. G., Gavrilenko A. V., Kalinin R. E., Chervjakov Ju. V. Jeffektivnost’ i bezopasnost’ primenenija preparata «Neovaskulgen» v kompleksnoj terapii pacientov s hronicheskoj ishemiej nizhnih konech¬nostej (II B – III faza klinicheskih ispytanij) // Kletochnaja transplantologija i tkanevaja inzhenerija. 2011. Vol. 6, № 3. P. 76–83.
Review
For citations:
Chervyakov Yu.V., Vlasenko O.N. COMPARISON OF THE EFFECTIVENESS OF GENE THERAPY AND STANDARD CONSERVATIVE THERAPY FOR PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA DUE TO ATHEROSCLEROSIS. Grekov's Bulletin of Surgery. 2018;177(2):64-69. (In Russ.) https://doi.org/10.24884/0042-4625-2018-177-2-64-69